At ASN Kidney Week 2025, Glucagon-like peptide-1 (GLP-1) receptor agonists moved firmly into the nephrology spotlight, with ...
At present, around 59 million adults worldwide have diabetes, about 64 million are diagnosed with heart failure, and ...
Medications like Ozempic mimic a naturally occurring hormone called glucagon-like peptide-1, or GLP-1, which helps regulate blood sugar and appetite. GLP-1 is primarily secreted from the intestines, ...
Many people enjoy a drink to unwind, a beer with colleagues, a glass of wine with dinner, or a whisky at the weekend. However ...
Scientists working at Harvard University have uncovered new evidence that molecules made by gut bacteria travel straight to ...
A federal judicial panel said Monday it would centralize a growing number of lawsuits against Novo Nordisk and Eli Lilly ...
Groundbreaking Harvard research reveals gut-produced molecules significantly influence obesity and blood sugar control. These ...
Dr Joshi: Vigilance is the key. The drugs must be taken under strict supervision. Common side effects like nausea, vomitting, ...
Danish Novo Nordisk launched its blockbuster treatment injection Ozempic in three forms in 0.25 mg, 0.5 mg and 1 mg in the ...
Congress has the power to make obesity treatment and weight management accessible to the communities that need it.
A new analysis suggests that people with type 2 diabetes who use GLP-1 medications like Ozempic, Trulicity or Victoza may be ...
The class of GLP-1 agonist medications act by lowering the appetite with applications way beyond diabetes. These medicines ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results